Racial divide in breast cancer, India’s cancer struggles, and other news

Here are a few highlights of cancer research news that have caught our attention the past two weeks:

  • The New York Times reports how India struggles to make cancer care more affordable, while drug companies are involved in patent disputes.
  • The difference in mortality rates between black women and white women with breast cancer has widened since 1975, according to the National Cancer Institute.
  • According to a study published in Cancer Immunology Research, engineered immune cells showed antitumor activity in two patients with advanced cancers.
  • According to a study published in Preventative Medicine, a diagnosis of cancer in a celebrity sharply increases efforts to quit smoking.

Great strides made in adolescent and young adult oncology and other news

Here are a few highlights of cancer research news that have caught our attention the past two weeks:

  • The Society of Adolescent and Young Adult Oncology (SAYAO) held their first annual meeting in October 2013, in Irvine, California. SAYAO “is an international professional organization dedicated to improving adolescent and young adult cancer care through the promotion of interdisciplinary research, education, communication, and collaboration among health professionals.”
  • The journal Science published research on a new cancer cell DNA damage repair mechanism.
  • MIT biologists have discovered that tumor cells with a p53 mutation can be made more vulnerable to chemotherapy by blocking the gene MK2.
  • Researchers from the Vanderbilt-Ingram Cancer Center have discovered new molecular targets for melanoma cancer patients.

Nutrition Recommendations Help Cancer Patients, and Other News

Here are a few highlights of cancer research news that have caught our attention the past two weeks:

  • The Cancer Nutrition Consortium, formed by seven leading cancer centers, including the Dana Farber Cancer Center, aims to help cancer patients make healthy choices in their diet to support their treatment.
  • Negative BRCA testing may not always imply lower breast cancer risk, according to research in the journal Cancer Epidemiology, Biomarkers & Prevention.
  •  The FDA announced the first regulatory approval of a high-throughput DNA sequencing device.
  • According to a study published in Cancer Epidemiology, Biomarkers & Prevention, sugary drinks increase endometrial cancer risk.